Media coverage
108
Media coverage
Title Jazz Pharmaceuticals Presents Overall Survival And Longer Follow-Up Data From HERIZON-BTC-01 Trial Evaluating Zanidatamab In Previously Treated HER2-Positive Biliary Tract Cancer At ASCO 2024 Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 1/06/24 Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet PR Newswire Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953498292&p=1gw&v=1&x=iwTfCioTJr8kaUb_wCNp4Q Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet InvestorsObserver Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953494825&p=1gw&v=1&x=ToWp5O5vmru_NpbV0xATjA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 1/06/24 URL ct.moreover.com/?a=53953474874&p=1gw&v=1&x=MDvUgQuIUGOGHvMa8nCqXQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet ADVFN UK Country/Territory United Kingdom Date 1/06/24 URL ct.moreover.com/?a=53953500378&p=1gw&v=1&x=AX2mbzBJc8SpqGTQHiLWBQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Finanzen.net Country/Territory Germany Date 1/06/24 URL ct.moreover.com/?a=53953526149&p=1gw&v=1&x=ha7bTJ-lvSbOI67r8_dGPw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Big Country Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953777748&p=1gw&v=1&x=crgCo26ffNTmuvw4TMyN2g Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet ProfitQuotes.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953480015&p=1gw&v=1&x=YInwc-RQWM_QwwK2vS6Qcw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Stockwatch Country/Territory Canada Date 1/06/24 URL ct.moreover.com/?a=53953480188&p=1gw&v=1&x=BRwsKrBo9sc9XYv6z6zLsw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet ADVFN US Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953486075&p=1gw&v=1&x=jCAthk2IeSp5v-z9D3BLUA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Crwe World Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953561579&p=1gw&v=1&x=Q9dpfdiIP6GRcQ-Y6bs9dg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Jazz Pharmaceuticals Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953642308&p=1gw&v=1&x=y-ZM7CJ7Ps6rvZT8anYPig Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet YourCentralValley.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953606305&p=1gw&v=1&x=sF7Dpa_vFQpmA4BEa09ViA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WJMN Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953607948&p=1gw&v=1&x=ETfSQbKkS0ZM_VuNUU6_DQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WeAreGreenBay.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953608596&p=1gw&v=1&x=rERIPXk3UVNkbabK6ylC_g Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WCIA.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953616286&p=1gw&v=1&x=dq-IlbatgCqoESTweMuwFQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WRIC TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953623469&p=1gw&v=1&x=4ftrGi6YVBSZNOJoghseVQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WVNS Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953623608&p=1gw&v=1&x=VwoQsFvxo5dNtin14On4Mg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WJTV.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953628271&p=1gw&v=1&x=MqHptlNAHRjGQBnvIR-aoA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet MyPanhandle.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953628837&p=1gw&v=1&x=IQi_WtVRF9J2tBnCHJZtFA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WJBF-TV Country/Territory Georgia Date 1/06/24 URL ct.moreover.com/?a=53953632262&p=1gw&v=1&x=zOU3qDbK3QSH8uNAFf9_gg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet ABC 27 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953638840&p=1gw&v=1&x=WC1VtPVX-lGhIIniXQC0dQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KODE TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953639704&p=1gw&v=1&x=n7ngvyOZYs8kmVgRs4S5ag Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WRBL-TV Country/Territory Georgia Date 1/06/24 URL ct.moreover.com/?a=53953647276&p=1gw&v=1&x=oR_nPLjuavPdsF22PapVbg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WKBN 27 First News Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953647386&p=1gw&v=1&x=4ugJoeAXUjJIYB4IH7L9Xg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Valleycentral.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953647879&p=1gw&v=1&x=y9zeYF1fESOjAvwW2K4XRg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WTVW FOX 7 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953648086&p=1gw&v=1&x=p46iqr2DmJXQlkbeMBcrjw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet CW33 NewsFix Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953652886&p=1gw&v=1&x=4Q8qVhGA5m3N306pxj__Vw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet ABC 4 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953652997&p=1gw&v=1&x=vE--YxnagcAhFb2uStCOQA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet MyStateLine.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953653261&p=1gw&v=1&x=g_jOMTG14yOXFMeJSiknyA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KFOR.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953653959&p=1gw&v=1&x=Hmo4iQwZ9aR-EZDhQliK9w Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WYTV News Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953658371&p=1gw&v=1&x=0mNYTFDL-1hVqDKUKH5ENQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet News Channel 8 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953658380&p=1gw&v=1&x=rzuA6L6lhmOuHh3Nmiag0g Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet CBS4Indy Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953658546&p=1gw&v=1&x=UaYNdGS7vAE--c-YvqigrQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WSPA.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953659156&p=1gw&v=1&x=tfBY4WlSNThCiLifcdDxOQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WOWK Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953662853&p=1gw&v=1&x=wNkHwfY9NijuUpIHLV_XIw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KSN Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953663383&p=1gw&v=1&x=OSmRuofKmF21w9nt4yfkiA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WFXRTV.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953663737&p=1gw&v=1&x=XkAONWgfDBGL4vRJo5ZRog Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WWLP.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953664606&p=1gw&v=1&x=_rocsqc_GvCpahmPTJSgfQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WesternSlopeNow.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953670216&p=1gw&v=1&x=rMHCwdbb2d2jnKD6SbBMNQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WIProud.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953670247&p=1gw&v=1&x=kyddcZtOnvbzjee6R9fQsw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WLNS Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953670322&p=1gw&v=1&x=uSFyxsib98aodMNdG8ND3w Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Binghamton Homepage Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953670378&p=1gw&v=1&x=vGlLZ9fWRKF8xhLfH35uDw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Fox 16 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953671202&p=1gw&v=1&x=rnYdwUv2OWc2Q8vXIXxwBw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Rochesterfirst.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953672001&p=1gw&v=1&x=5xMUGQtVT_-Q2V4jwqIROA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WHNT-TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953672148&p=1gw&v=1&x=mkwSYlOa4PDvGgFARDXanQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WJHL.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953674990&p=1gw&v=1&x=1-xG6G7wEJQbB-vAbLSISw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WBOY Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953677646&p=1gw&v=1&x=sKcH_El_swc7G5SMPgraxA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Fox 4 WDAF TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953678074&p=1gw&v=1&x=WKt1VRppQ50kGBbiW1r6CQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Fox40 KTXL Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953678197&p=1gw&v=1&x=q5fXpsBprSScW_fsWEoOgQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WTRF Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953704486&p=1gw&v=1&x=3oiIyVOB4_Y5l2Y2uWcdgA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet LocalSRY.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953705804&p=1gw&v=1&x=VXd2Cxte5uuZQsze2rhmSw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet FOX5 San Diego Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953706524&p=1gw&v=1&x=2fuYWVjuPJyZ4lJe0ysAug Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet CNYHomepage.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953709121&p=1gw&v=1&x=imIjvK_gZpGpLpiZOQEz3g Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet INFORMNNY.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953711137&p=1gw&v=1&x=3uSLairVIrCWnnrwOM2wWQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KLFY Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953711648&p=1gw&v=1&x=fGPVWcuqHS2MVXvlHVe0JA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet CW39 NewsFix Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953713365&p=1gw&v=1&x=O3bN-bra4OL1JVLlJ8ZqIA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KHON 2 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953713882&p=1gw&v=1&x=YCvi7KN87wCqHlZG_akfkA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KXAN Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953714855&p=1gw&v=1&x=hQvhovgI6zLfYH3TP11h7Q Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet CBS17.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953715529&p=1gw&v=1&x=ZldDAdBfhZSBUi_2EK3Epg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WDHN Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953717201&p=1gw&v=1&x=MxSut8_3sSAHFPExfneNOg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KRON4 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953717437&p=1gw&v=1&x=vawOYq6r9h2OTULD5sT2jg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Siouxland Matters Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953720186&p=1gw&v=1&x=OrA3G1EENm4N4yP8A9dq0Q Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WTen.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953720456&p=1gw&v=1&x=xy1x0xQKZseuafU89s4UWw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet FOX 59 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953720561&p=1gw&v=1&x=semDGE81UEGsFW3z2PZyVw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet MyHighPlains.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953720635&p=1gw&v=1&x=pV3zoLn-OQwkP1hWZF56Og Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WPRI Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953720966&p=1gw&v=1&x=7TnU71MdI2rkbSmQx4xPXQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WTWO Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953721839&p=1gw&v=1&x=K18Wnc4cZUZCIgIeeoxFNw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KRQE Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953727965&p=1gw&v=1&x=M_6G8XCevj8niOLuk5HMIA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KNWA Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953728897&p=1gw&v=1&x=Pa5bXSW2mNXrPg09a2DeXA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet OzarksFirst.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953729058&p=1gw&v=1&x=VeGJrnhBQbRNcEjZVOU_MQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Wavy Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953730139&p=1gw&v=1&x=iOC3y0PdLyavfffQv5A0-A Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet NBC4 Columbus Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953731017&p=1gw&v=1&x=tYk2OOfPUq5zoLqEnW5z8g Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet FOX8 WGHP Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953734394&p=1gw&v=1&x=Z9wQr03du9cVh0QT1ammEA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet Kark.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953734424&p=1gw&v=1&x=eicoRv0N25baotF7XcSlrQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WKRG Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953735380&p=1gw&v=1&x=FT1MeRPlmY714oL2SwRVBg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet 8 News Now Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953738144&p=1gw&v=1&x=SEVxr9t0fyQaa-7JXzThDw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WYOU Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953739433&p=1gw&v=1&x=-2kqrf9d0a9CyvUa8-yVqg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet My Champlain Valley Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953741006&p=1gw&v=1&x=g1zAsayUncKP6r0wsbQuCA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KELOLAND TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953741404&p=1gw&v=1&x=v0mZt8lOhCfXMP4j38xYrg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WGNO Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953744026&p=1gw&v=1&x=EJiN4bGxlpPNa6kTydWujg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet KSNT TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953750287&p=1gw&v=1&x=izYwEniJ9T_S1szNUE0OVQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WETM 18 Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953763139&p=1gw&v=1&x=_xqPjG56JScVgvyDrUySqA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet ConchoValleyHomepage.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953765074&p=1gw&v=1&x=VaE8ima0nIOh4cl6cZWNgQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet FOX21News.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953768360&p=1gw&v=1&x=iOwhu8Ayav84t27HL8I_OQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WANE-TV Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953771731&p=1gw&v=1&x=6uctkXJPT2pxoHmiFoa_aQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WDTN Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953772188&p=1gw&v=1&x=v4OEnQSHIUPBXwGPgM_RxQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WNTZ Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953773814&p=1gw&v=1&x=4E1cyYtfh9g9d0kspN4A8w Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WCBD Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953777591&p=1gw&v=1&x=u-4Wh_SKLPl2-cDM2zAtcQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet FOX 31 News KDVR Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953798477&p=1gw&v=1&x=ZB11RBGFk01zl1n3aF2tRw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet WREG Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953798958&p=1gw&v=1&x=KL9QJx8shNeMM4X26jFzbw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 Media name/outlet YOUR BASIN Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953814118&p=1gw&v=1&x=_mOPWDXVM3j-Xn5dkUr2KA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet L' Observateur Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953506905&p=1gw&v=1&x=Tg61JEZcByUAVEGieVlKBQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Elizabethton.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953510522&p=1gw&v=1&x=mph_g-hfyvV7KwjwYjizKw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet TheTidewaterNews.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953514340&p=1gw&v=1&x=1B4kvxEnRLzSmGXHnbo-cQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Jessamine Journal Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953515151&p=1gw&v=1&x=mK57bhaZcaoNm_pcQFqjrA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Suffolk News Herald Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953522050&p=1gw&v=1&x=cFjFD3HF5VWTHYmpLwvofw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet LaGrange Daily News Country/Territory Georgia Date 1/06/24 URL ct.moreover.com/?a=53953524328&p=1gw&v=1&x=0IGbIQbQgAk6C-49scE7BQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Port Arthur News Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953531668&p=1gw&v=1&x=20WkMQTLOqm76FvNuBREUw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Winchester Sun Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953531786&p=1gw&v=1&x=JiuW4M9ncKyShJqcrshbYg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953538653&p=1gw&v=1&x=tbuvaxAbk7DV1MgXfrdDeA Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet BluegrassLive.com Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953542381&p=1gw&v=1&x=x8nKwF3PQ6bw8dt44D9ZUQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Times of San Diego Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953542382&p=1gw&v=1&x=7mQitO6Ax92DBUMRtxMFFw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953550485&p=1gw&v=1&x=HQvkRlWCFvd3M7QLLlzEfQ Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Luverne Journal Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953566327&p=1gw&v=1&x=gJpMiA1RGeRXvF-y0S-ILw Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously... Media name/outlet Smithfield Times Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953568803&p=1gw&v=1&x=jIG-VOf6PecYjpNcaSl5Rg Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953584307&p=1gw&v=1&x=AYY-1q8Nlu_bYEfAyC2Y9Q Persons Jin-A Choi Title Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Media name/outlet Leesville Leader Country/Territory United States Date 1/06/24 URL ct.moreover.com/?a=53953589572&p=1gw&v=1&x=yWIoBe5D_FUnQuFlK6MR_g Persons Jin-A Choi